Structural Basis for the Activity of Drugs that Inhibit Phosphodiesterases

Article Properties
  • Language
    English
  • Publication Date
    2004/12/01
  • Journal
  • Indian UGC (journal)
  • Refrences
    52
  • Citations
    302
  • Graeme L. Card
  • Bruce P. England
  • Yoshihisa Suzuki
  • Daniel Fong
  • Ben Powell
  • Byunghun Lee
  • Catherine Luu
  • Maryam Tabrizizad
  • Sam Gillette
  • Prabha N. Ibrahim
  • Dean R. Artis
  • Gideon Bollag
  • Michael V. Milburn
  • Sung-Hou Kim
  • Joseph Schlessinger
  • Kam Y.J. Zhang
Cite
Card, Graeme L., et al. “Structural Basis for the Activity of Drugs That Inhibit Phosphodiesterases”. Structure, vol. 12, no. 12, 2004, pp. 2233-47, https://doi.org/10.1016/j.str.2004.10.004.
Card, G. L., England, B. P., Suzuki, Y., Fong, D., Powell, B., Lee, B., Luu, C., Tabrizizad, M., Gillette, S., Ibrahim, P. N., Artis, D. R., Bollag, G., Milburn, M. V., Kim, S.-H., Schlessinger, J., & Zhang, K. Y. (2004). Structural Basis for the Activity of Drugs that Inhibit Phosphodiesterases. Structure, 12(12), 2233-2247. https://doi.org/10.1016/j.str.2004.10.004
Card, Graeme L., Bruce P. England, Yoshihisa Suzuki, Daniel Fong, Ben Powell, Byunghun Lee, Catherine Luu, et al. “Structural Basis for the Activity of Drugs That Inhibit Phosphodiesterases”. Structure 12, no. 12 (2004): 2233-47. https://doi.org/10.1016/j.str.2004.10.004.
Card GL, England BP, Suzuki Y, Fong D, Powell B, Lee B, et al. Structural Basis for the Activity of Drugs that Inhibit Phosphodiesterases. Structure. 2004;12(12):2233-47.
Refrences
Title Journal Journal Categories Citations Publication Date
Crystal Structures of the Catalytic Domain of Phosphodiesterase 4B Complexed with AMP, 8-Br-AMP, and Rolipram Journal of Molecular Biology
  • Science: Biology (General)
  • Science: Biology (General): Genetics
78 2004
Crystal structure of phosphodiesterase 9 shows orientation variation of inhibitor 3-isobutyl-1-methylxanthine binding

Proceedings of the National Academy of Sciences
  • Science: Science (General)
62 2004
Automated protein crystal structure determination using elves

Proceedings of the National Academy of Sciences
  • Science: Science (General)
159 2004
Crystal Structure of Human Phosphodiesterase 3B:  Atomic Basis for Substrate and Inhibitor Specificity Biochemistry
  • Science: Biology (General)
  • Science: Biology (General)
  • Science: Chemistry: Organic chemistry: Biochemistry
  • Science: Biology (General)
  • Science: Chemistry: Organic chemistry: Biochemistry
84 2004
A Glutamine Switch Mechanism for Nucleotide Selectivity by Phosphodiesterases Molecular Cell
  • Science: Biology (General)
  • Science: Biology (General): Cytology
  • Science: Biology (General): Cytology
  • Science: Biology (General): Genetics
202 2004
Citations
Title Journal Journal Categories Citations Publication Date
FDA approved fluorine-containing drugs in 2023 Chinese Chemical Letters
  • Science: Chemistry: General. Including alchemy
  • Science: Chemistry
2024
Advances in targeting Phosphodiesterase 1: From mechanisms to potential therapeutics European Journal of Medicinal Chemistry
  • Medicine: Therapeutics. Pharmacology
  • Science: Chemistry: Analytical chemistry
  • Science: Chemistry
2024
ME3183, a novel phosphodiesterase-4 inhibitor, exhibits potent anti-inflammatory effects and is well tolerated in a non-clinical study European Journal of Pharmacology
  • Medicine: Public aspects of medicine: Toxicology. Poisons
  • Medicine: Therapeutics. Pharmacology
1 2024
Identification of Dihydrobenzofuran Neolignans as Novel PDE4 Inhibitors and Evaluation of Antiatopic Dermatitis Efficacy in DNCB-Induced Mice Model Journal of Medicinal Chemistry
  • Medicine: Therapeutics. Pharmacology
  • Science: Chemistry: Analytical chemistry
  • Science: Chemistry
2024
cAMP binding to closed pacemaker ion channels is cooperative

Proceedings of the National Academy of Sciences
  • Science: Science (General)
1 2024
Citations Analysis
Category Category Repetition
Medicine: Therapeutics. Pharmacology178
Science: Chemistry148
Science: Chemistry: Analytical chemistry111
Science: Biology (General)80
Medicine: Public aspects of medicine: Toxicology. Poisons55
Science: Chemistry: Organic chemistry: Biochemistry53
Science: Chemistry: Organic chemistry49
Science: Chemistry: General. Including alchemy39
Science: Mathematics: Instruments and machines: Electronic computers. Computer science23
Science: Physics13
Science: Science (General): Cybernetics: Information theory13
Technology: Chemical technology: Polymers and polymer manufacture11
Science: Chemistry: Physical and theoretical chemistry8
Medicine: Medicine (General)8
Medicine: Medicine (General): Computer applications to medicine. Medical informatics8
Technology: Chemical technology: Biotechnology7
Science: Biology (General): Genetics7
Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry7
Science: Science (General)6
Science: Botany: Plant ecology6
Science: Microbiology5
Science: Physics: Atomic physics. Constitution and properties of matter5
Science: Biology (General): Cytology5
Agriculture4
Agriculture: Agriculture (General)4
Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy4
Science3
Science: Chemistry: Crystallography3
Science: Botany2
Agriculture: Plant culture2
Agriculture: Animal culture2
Science: Chemistry: Inorganic chemistry2
Medicine2
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the endocrine glands. Clinical endocrinology2
Medicine: Internal medicine: Special situations and conditions: Arctic medicine. Tropical medicine2
Medicine: Public aspects of medicine2
Medicine: Internal medicine: Infectious and parasitic diseases2
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the respiratory system2
Medicine: Internal medicine1
Medicine: Other systems of medicine1
Science: Zoology1
Technology: Electrical engineering. Electronics. Nuclear engineering: Nuclear engineering. Atomic power1
Medicine: Medicine (General): Medical physics. Medical radiology. Nuclear medicine1
Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens1
Technology: Chemical technology: Food processing and manufacture1
Technology: Home economics: Nutrition. Foods and food supply1
Technology: Chemical technology: Chemical engineering1
Medicine: Medicine (General): Medical technology1
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the musculoskeletal system1
Medicine: Internal medicine: Special situations and conditions1
Medicine: Internal medicine: Medical emergencies. Critical care. Intensive care. First aid1
Medicine: Surgery: Anesthesiology1
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the circulatory (Cardiovascular) system1
Medicine: Pharmacy and materia medica1
Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry: Neurology. Diseases of the nervous system: Psychiatry1
Science: Physics: Nuclear and particle physics. Atomic energy. Radioactivity1
The category Medicine: Therapeutics. Pharmacology 178 is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled A FYVE‐containing unusual cyclic nucleotide phosphodiesterase from Trypanosoma cruzi and was published in 2005. The most recent citation comes from a 2024 study titled Identification of Dihydrobenzofuran Neolignans as Novel PDE4 Inhibitors and Evaluation of Antiatopic Dermatitis Efficacy in DNCB-Induced Mice Model. This article reached its peak citation in 2023, with 24 citations. It has been cited in 129 different journals, 18% of which are open access. Among related journals, the Journal of Medicinal Chemistry cited this research the most, with 35 citations. The chart below illustrates the annual citation trends for this article.
Citations used this article by year